Natco Pharma USA (formerly DASH Pharmaceuticals) is the United States subsidiary of Natco Pharma Limited. We’re a pharmaceutical company engaged in developing, manufacturing and marketing generic finished dosage formulations (FDFs) and active pharmaceutical ingredients (APIs). Our specialty is in niche therapeutic areas and producing complex products – with the ultimate goal of increasing access to affordable medicines that meet the highest standards of quality, supply reliability and customer service.
We’re a trusted supplier of medicines, as evidenced by our work with some of the world’s largest generic pharmaceutical companies. Natco has co-developed, manufactured, and supplied several first-time generic and complex generic products in the U.S. market, including Lenalidomide Capsules, Oseltamivir Capsules, Lapatinib Tablets, Everolimus Tablets, Glatiramer Acetate Pre-Filled Syringes, and Liposomal Doxorubicin Vials.
Company Details
- Employees
- 7
- Address
- 300 Interpace Pkwy, Suite 100
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.natcopharmausa.com
- HQ
- Parsippany, New Jersey
Natco Pharma Usa Questions
Natco Pharma Usa's website is https://www.natcopharmausa.com
Natco Pharma Usa's LinkedIn profile is https://www.linkedin.com/company/natcopharmausa
Natco Pharma Usa has
7 employees.
View email and phone details for 7
employees at Natco Pharma Usa.
Natco Pharma Usa's industry is
Pharmaceutical Manufacturing
Natco Pharma Usa's top competitors are
Natco Pharma Limited - India,
Natco Pharma,
Amneal Pharmaceuticals,
Hetero Usa Inc,
Aurobindo Pharma Usa, Inc.,
Natco Lifesciences Philippines Inc.,
Dash Pharmaceuticals Llc,
Natcofarma Brasil,
Natco Pharma (Canada) Inc.,
Cipla Usa.
Natco Pharma Usa's categories are Pharmaceutical Manufacturing
